John M. Hilfinger

1.8k total citations
44 papers, 1.5k citations indexed

About

John M. Hilfinger is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, John M. Hilfinger has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Infectious Diseases. Recurrent topics in John M. Hilfinger's work include Biochemical and Molecular Research (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). John M. Hilfinger is often cited by papers focused on Biochemical and Molecular Research (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). John M. Hilfinger collaborates with scholars based in United States, Türkiye and Switzerland. John M. Hilfinger's co-authors include Gordon L. Amidon, Yasuhiro Tsume, Blake J. Roessler, Elke Walter, Christopher P. Landowski, Balvinder S. Vig, Philip L. Lorenzi, Arik Dahan, Xueqin Song and Xueqin Song and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Journal of Controlled Release.

In The Last Decade

John M. Hilfinger

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Hilfinger United States 22 641 507 331 297 175 44 1.5k
Reza Oliyai United States 13 855 1.3× 231 0.5× 207 0.6× 327 1.1× 434 2.5× 21 1.8k
Jonathan Cheong United States 13 444 0.7× 412 0.8× 151 0.5× 161 0.5× 140 0.8× 30 1.3k
Yasuhiro Tsume United States 27 499 0.8× 460 0.9× 1.0k 3.1× 121 0.4× 109 0.6× 54 1.9k
Balvinder S. Vig United States 18 464 0.7× 329 0.6× 141 0.4× 142 0.5× 150 0.9× 26 973
Günther Wess Germany 20 532 0.8× 638 1.3× 110 0.3× 86 0.3× 316 1.8× 33 1.3k
Harold E. Selick United States 11 833 1.3× 408 0.8× 162 0.5× 63 0.2× 171 1.0× 13 1.8k
Yue Weng China 13 894 1.4× 1.2k 2.3× 111 0.3× 308 1.0× 535 3.1× 34 2.2k
Robert L. Shepard United States 24 831 1.3× 1.3k 2.6× 68 0.2× 318 1.1× 111 0.6× 34 2.0k
Doo-Man Oh United States 4 588 0.9× 186 0.4× 165 0.5× 116 0.4× 284 1.6× 6 1.3k
Hanna Kumpulainen Finland 5 601 0.9× 170 0.3× 151 0.5× 126 0.4× 305 1.7× 8 1.3k

Countries citing papers authored by John M. Hilfinger

Since Specialization
Citations

This map shows the geographic impact of John M. Hilfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Hilfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Hilfinger more than expected).

Fields of papers citing papers by John M. Hilfinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Hilfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Hilfinger. The network helps show where John M. Hilfinger may publish in the future.

Co-authorship network of co-authors of John M. Hilfinger

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Hilfinger. A scholar is included among the top collaborators of John M. Hilfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Hilfinger. John M. Hilfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jing, Yasuhiro Tsume, Hao Xu, et al.. (2016). Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. Journal of Pharmaceutical Sciences. 105(2). 925–934. 18 indexed citations
2.
Tsume, Yasuhiro, et al.. (2013). The development of orally administrable gemcitabine prodrugs with d-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability. European Journal of Pharmaceutics and Biopharmaceutics. 86(3). 514–523. 35 indexed citations
3.
McKenna, Charles E., et al.. (2011). Amido tyrosine esters: a promising new approach to antiviral nucleoside phosphonate prodrugs. Antiviral Research. 90(2). A23–A24. 1 indexed citations
4.
Peterson, Larryn W., Jae‐Seung Kim, John M. Hilfinger, et al.. (2011). Synthesis, transport and antiviral activity of Ala–Ser and Val–Ser prodrugs of cidofovir. Bioorganic & Medicinal Chemistry Letters. 21(13). 4045–4049. 10 indexed citations
5.
Shen, Wei, et al.. (2009). 5′-O-D-ValylaraA, A Potential Prodrug for Improving Oral Bioavailability of the Antiviral Agent Vidarabine. Nucleosides Nucleotides & Nucleic Acids. 28(1). 43–55. 12 indexed citations
6.
Sala‐Rabanal, Monica, Larryn W. Peterson, Michaela Serpi, et al.. (2009). Interactions Between the Human Oligopeptide Transporter, hPepT1 and Serine Side-chain-linked Cidofovir Prodrugs. Antiviral Research. 82(2). A53–A54. 1 indexed citations
7.
Nelson, Cara, Larryn W. Peterson, Chester J. Provoda, et al.. (2009). Puromycin-sensitive aminopeptidase: An antiviral prodrug activating enzyme. Antiviral Research. 85(3). 482–489. 7 indexed citations
8.
Tsume, Yasuhiro, John M. Hilfinger, & Gordon L. Amidon. (2008). Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability. Molecular Pharmaceutics. 5(5). 717–727. 62 indexed citations
9.
Hilfinger, John M., et al.. (2008). Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms. Pharmaceutical Research. 25(7). 1591–1600. 63 indexed citations
10.
Shen, Wei, Jae‐Seung Kim, Phillip E. Kish, et al.. (2008). Design and synthesis of vidarabine prodrugs as antiviral agents. Bioorganic & Medicinal Chemistry Letters. 19(3). 792–796. 34 indexed citations
11.
Eriksson, Ulrika, Larryn W. Peterson, B. A. Kashemirov, et al.. (2008). Serine Peptide Phosphoester Prodrugs of Cyclic Cidofovir: Synthesis, Transport, and Antiviral Activity. Molecular Pharmaceutics. 5(4). 598–609. 33 indexed citations
12.
Mittal, Sachin, Yasuhiro Tsume, Christopher P. Landowski, et al.. (2007). Proline prodrug of melphalan, prophalan-l, demonstrates high therapeutic index in a murine melanoma model. European Journal of Pharmaceutics and Biopharmaceutics. 67(3). 752–758. 8 indexed citations
13.
Eriksson, Ulrika, John M. Hilfinger, Jae‐Seung Kim, et al.. (2006). Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir. Bioorganic & Medicinal Chemistry Letters. 17(3). 583–586. 14 indexed citations
14.
Lorenzi, Philip L., Christopher P. Landowski, Xueqin Song, et al.. (2005). Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-(β-d-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 314(2). 883–890. 19 indexed citations
15.
Landowski, Christopher P., Xueqin Song, Philip L. Lorenzi, John M. Hilfinger, & Gordon L. Amidon. (2005). Floxuridine Amino Acid Ester Prodrugs: Enhancing Caco-2 Permeability and Resistance to Glycosidic Bond Metabolism. Pharmaceutical Research. 22(9). 1510–1518. 58 indexed citations
16.
Mittal, Sachin, Xueqin Song, Balvinder S. Vig, et al.. (2005). Prolidase, a Potential Enzyme Target for Melanoma:  Design of Proline-Containing Dipeptide-like Prodrugs. Molecular Pharmaceutics. 2(1). 37–46. 38 indexed citations
17.
Delaney, Bryan, John M. Hilfinger, Jae Seung Kim, et al.. (2004). Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats. The Journal of Nutritional Biochemistry. 15(5). 289–295. 28 indexed citations
18.
Hsu, Cheng‐Pang, John M. Hilfinger, Elke Walter, et al.. (1998). Overexpression of Human Intestinal Oligopeptide Transporter in Mammalian Cells via Adenoviral Transduction. Pharmaceutical Research. 15(9). 1376–1381. 20 indexed citations
19.
Croyle, Maria A., Blake J. Roessler, Beverly L. Davidson, John M. Hilfinger, & Gordon L. Amidon. (1998). Factors that Influence Stability of Recombinant Adenoviral Preparations for Human Gene Therapy. Pharmaceutical Development and Technology. 3(3). 373–383. 59 indexed citations
20.
Walter, Elke, et al.. (1996). HT29-MTX/Caco-2 Cocultures as an in Vitro Model for the Intestinal Epithelium: In Vitro–in Vivo Correlation with Permeability Data from Rats and Humans. Journal of Pharmaceutical Sciences. 85(10). 1070–1076. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reza Oliyai Breakdown of academic impact, for papers by Jonathan Cheong Breakdown of academic impact, for papers by Yasuhiro Tsume Breakdown of academic impact, for papers by Balvinder S. Vig Breakdown of academic impact, for papers by Günther Wess Breakdown of academic impact, for papers by Harold E. Selick Breakdown of academic impact, for papers by Yue Weng Breakdown of academic impact, for papers by Robert L. Shepard Breakdown of academic impact, for papers by Doo-Man Oh Breakdown of academic impact, for papers by Hanna Kumpulainen
Rankless by CCL
2026